Despite its leadership in pharmaceutical products for diabetes, Sanofi is not a market leader in blood glucose meters and devices, with firms such as Abbott Diabetes Care and Bayer having a ...
French pharma major Sanofi today announced an investment of 40 million euros ($42.4 million) in its Lyon Gerland ...
Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
medicines for diabetes and cardiovascular diseases; and established prescription products. Receive News & Ratings for Sanofi ...
Sanofi India net profit down 46% in quarter ended September 30: Our Bureau, New Delhi Friday, November 8, 2024, 11:35 Hrs [IST] Sanofi India has registered 46 per cent decline in ...
Sanofi has an analyst consensus ... specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities.
Sanofi (NASDAQ:SNY – Free Report) by 30.4% during the third quarter, according to the company in its most recent filing with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback